Dr. Pierre-olivier Champagne

Dr. Gardner is the Peter J. Jannetta Endowed Chair of neurological surgery at the University of Pittsburgh School of Medicine and director of the Center for Skull Base Surgery. He specializes in endoscopic endonasal skull base surgery, pituitary tumors, Neuroendoport brain surgery, and vascular neurosurgery. Dr. Gardner is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Chordoma, Pituitary Tumor, Meningioma, Nerve Decompression, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Gardner is board certified in American Board Of Neurological Surgery. Dr. Gardner is currently accepting new patients.

Dr. Lunsford is the Lars Leksell Professor and Distinguished Professor of neurological surgery at the University of Pittsburgh School of Medicine. He is also the director of the Center for Image-Guided Neurosurgery and the Residency Training Program at UPMC. Dr. Lunsford is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Meningioma, Acoustic Neuroma, Schwannoma, Gamma Knife Radiosurgery, and Thalamotomy. Dr. Lunsford is board certified in American Board Of Neurological Surgery.

Dr. Zinn is assistant professor of neurological surgery at the University of Pittsburgh School of Medicine and associate director of the Adult Neurosurgical Oncology Program. He specializes in neurosurgical oncology.Dr. Zinn received his medical degree from the University of Zurich in Switzerland and received his PhD from the University of Lausanne. He completed his neurosurgery residency at Baylor College of Medicine and MD Anderson Cancer Center. He then completed a fellowship at Dana-Farber Cancer Institute, Harvard Medical School.In addition to his clinical focus in neuro-oncology, Dr. Zinn’s research focuses on patient-centered care for brain and spinal tumors. Utilizing humanoid brain organoid cancer models, Dr. Zinn simulates the patient’s tumor condition in the laboratory and studies the origins of how the tumor forms and how tumors can be treated using tumor genetics precision approaches. Furthermore, Dr. Zinn is developing personalized biologically-adaptable and patient-tailored, virus-based therapies for brain cancer.Pascal Zinn, MD, PhD, specializes in surgical oncology and neurosurgery. He practices at University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Shadyside. He completed his residency at Baylor College of Medicine and medical degree at University of Zurich. Dr. Zinn is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Cordotomy. Dr. Zinn is board certified in American Board Of Neurological Surgery. Dr. Zinn is currently accepting new patients.